Davos Alzheimer's Collaborative Study: Sequential Administration of Digital Testing To Screen For Cognitive Impairment Followed By Blood Based Biomarkers To Assist With Timely Detection And Accurate Diagnosis Of Alzheimer's Disease

Clinical trial NCT05379348 · COMPLETED

Trial details

NCT number: NCT05379348
Sponsor: AdventHealth Translational Research Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Alzheimer Disease

Start date: 2022-03-14
Primary completion: 2025-08-05
Enrollment: 1423

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.